Jennifer Kerkhof Selected Research

RNA (Ribonucleic Acid)

1/2022	OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants.
1/2022	Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.
10/2019	Genome-wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome.
9/2019	Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer Kerkhof Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 10/2020
4	Neurodevelopmental Disorders 01/2023 - 11/2021
3	Kabuki syndrome 01/2022 - 10/2019
2	Intellectual Disability (Idiocy) 02/2024 - 11/2022
2	Carcinogenesis 02/2024 - 05/2023
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 03/2024
1	Brachydactyly 02/2024
1	Cleft Palate (Palate, Cleft) 02/2024
1	Autism Spectrum Disorder 02/2024
1	Chromosome Fragility 11/2023
1	Rare Diseases (Rare Disease) 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023
1	Bone Marrow Failure Disorders 09/2023
1	Renpenning syndrome 1 01/2023
1	Disease Progression 01/2023
1	Muscle Weakness 01/2023
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023
1	Clark-Baraitser syndrome 11/2022
1	Pelger-Huet Anomaly 10/2022
1	Autistic Disorder (Autism) 10/2022
1	DiGeorge Syndrome (Syndrome, DiGeorge) 08/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Adenocarcinoma 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 09/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 10/2018
1	Free sialic acid storage disease 10/2018

Drug/Important Bio-Agent (IBA)

5	ChromatinIBA 10/2022 - 08/2021
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 10/2020
4	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2019
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
3	A-Form DNA (A-DNA)IBA 01/2023 - 09/2019
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2024
2	Transcription Factors (Transcription Factor)IBA 02/2024 - 05/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2020
1	Retinaldehyde (Retinal)IBA 09/2023
1	DystrophinIBA 01/2023
1	Lysine AcetyltransferasesIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	polyglutamine-binding protein 1IBA 01/2023
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 11/2022
1	ElementsIBA 11/2022
1	PlatinumIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 10/2018
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2018

Therapy/Procedure

1	Therapeutics 01/2023
1	Molecular Targeted Therapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2022